Daniel Clarke

508 total citations
20 papers, 352 citations indexed

About

Daniel Clarke is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Daniel Clarke has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Daniel Clarke's work include Virus-based gene therapy research (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA Interference and Gene Delivery (3 papers). Daniel Clarke is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA Interference and Gene Delivery (3 papers). Daniel Clarke collaborates with scholars based in Australia, United Kingdom and Bangladesh. Daniel Clarke's co-authors include Nigel A.J. McMillan, Denis Wakefield, Peter McCluskey, Adi Idris, Mushfiq Hassan Shaikh, Newell W. Johnson, P. Naish, Robert A. Phillips, Peter Carson and Paul R. Young and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Daniel Clarke

20 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Clarke Australia 10 135 72 70 59 54 20 352
Usha Kim India 16 156 1.2× 84 1.2× 57 0.8× 62 1.1× 38 0.7× 65 696
J.J.N. Costa Brazil 16 237 1.8× 181 2.5× 89 1.3× 40 0.7× 101 1.9× 37 692
Emma Jaeger United Kingdom 10 149 1.1× 138 1.9× 71 1.0× 36 0.6× 63 1.2× 13 580
Kazuhide Okazawa Japan 7 151 1.1× 71 1.0× 191 2.7× 18 0.3× 53 1.0× 8 474
Ivana Majstorović Serbia 14 134 1.0× 43 0.6× 30 0.4× 22 0.4× 240 4.4× 31 554
Ya‐Ping Ko Germany 12 222 1.6× 87 1.2× 53 0.8× 81 1.4× 55 1.0× 14 532
Monique G.C.T. van Oijen Netherlands 11 178 1.3× 155 2.2× 48 0.7× 11 0.2× 105 1.9× 11 543
Weimin Tsai United States 14 201 1.5× 101 1.4× 84 1.2× 28 0.5× 143 2.6× 19 573
Caroline Lynas United Kingdom 11 119 0.9× 114 1.6× 295 4.2× 20 0.3× 54 1.0× 17 559
Rkia Dardari Canada 14 97 0.7× 185 2.6× 57 0.8× 14 0.2× 102 1.9× 25 458

Countries citing papers authored by Daniel Clarke

Since Specialization
Citations

This map shows the geographic impact of Daniel Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Clarke more than expected).

Fields of papers citing papers by Daniel Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Clarke. The network helps show where Daniel Clarke may publish in the future.

Co-authorship network of co-authors of Daniel Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Clarke. A scholar is included among the top collaborators of Daniel Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Clarke. Daniel Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Supramaniam, Aroon, Yaman Tayyar, Daniel Clarke, et al.. (2023). Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection. Journal of Microbiology Immunology and Infection. 56(3). 516–525. 16 indexed citations
2.
Clarke, Daniel, et al.. (2023). Biologics in peripheral ulcerative keratitis. Seminars in Arthritis and Rheumatism. 63. 152269–152269. 1 indexed citations
3.
Wakefield, Denis, Daniel Clarke, & Peter McCluskey. (2021). Recent Developments in HLA B27 Anterior Uveitis. Frontiers in Immunology. 11. 608134–608134. 39 indexed citations
4.
Martinez, Cristina, et al.. (2021). Integrated field assessment of nitrogen release dynamics and crop recovery of band-applied controlled-release fertilisers. Plant and Soil. 466(1-2). 257–273. 12 indexed citations
5.
Goddard, Sarah, et al.. (2021). Impact of stopping long‐term immunoglobulin therapy in patients with secondary antibody deficiency due to haematological disease. British Journal of Haematology. 193(2). e12–e15. 3 indexed citations
6.
Clarke, Daniel, et al.. (2020). Antimicrobial stewardship in spinal cord injury: A multidisciplinary approach. Journal of Spinal Cord Medicine. 44(5). 770–774. 5 indexed citations
7.
Tayyar, Yaman, Andrew C. Bulmer, Alfred K. Lam, et al.. (2019). Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237. PLoS ONE. 14(11). e0225774–e0225774. 4 indexed citations
8.
Clarke, Daniel, Adi Idris, & Nigel A.J. McMillan. (2019). Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage. PLoS ONE. 14(2). e0211954–e0211954. 8 indexed citations
9.
Shaikh, Mushfiq Hassan, Adi Idris, Newell W. Johnson, et al.. (2018). Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers. Oral Oncology. 86. 105–112. 28 indexed citations
10.
Clarke, Daniel, et al.. (2018). RNAi Targeting of Human Metapneumovirus <b><i>P</i></b> and <b><i>N</i></b> Genes Inhibits Viral Growth. Intervirology. 61(3). 149–154. 9 indexed citations
11.
Shaikh, Mushfiq Hassan, Daniel Clarke, Newell W. Johnson, & Nigel A.J. McMillan. (2017). Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?. Oral Oncology. 68. 9–19. 15 indexed citations
12.
Shaikh, Mushfiq Hassan, Vinod Gopalan, Alfred K. Lam, et al.. (2017). Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh. BMC Cancer. 17(1). 792–792. 25 indexed citations
13.
Sheng, Yonghua, Yaowu He, Sumaira Z. Hasnain, et al.. (2016). MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target. Oncogene. 36(5). 700–713. 63 indexed citations
14.
He, Yaowu, Sumaira Z. Hasnain, Ran Wang, et al.. (2016). Abstract 3564: MUC13 protects colorectal cancer cells from death by activating the NF-κb pathway and is a potential therapeutic target. Cancer Research. 76(14_Supplement). 3564–3564. 2 indexed citations
15.
Gabrielli, Brian, Max V. Ranall, Zay Yar Oo, et al.. (2015). Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer. Molecular Cancer Therapeutics. 14(12). 2753–2761. 35 indexed citations
16.
Simmons, G. C., J. Meers, Daniel Clarke, et al.. (2014). The origins and ecological impact of koala retrovirus. Griffith Research Online (Griffith University, Queensland, Australia). 24. 31–33. 2 indexed citations
17.
Simmons, G. C., Daniel Clarke, Jeff J. McKee, Paul R. Young, & J. Meers. (2014). Discovery of a Novel Retrovirus Sequence in an Australian Native Rodent (Melomys burtoni): A Putative Link between Gibbon Ape Leukemia Virus and Koala Retrovirus. PLoS ONE. 9(9). e106954–e106954. 32 indexed citations
18.
Meers, J., et al.. (2014). Koala retrovirus in free-ranging populations—prevalence. Griffith Research Online (Griffith University, Queensland, Australia). 24. 15–17. 4 indexed citations
19.
Clarke, Daniel, Aaron T. Irving, Eleanore Lambley, Elizabeth Payne, & Nigel A.J. McMillan. (2004). A Novel Method for Screening Viral Interferon-Resistance Genes. Journal of Interferon & Cytokine Research. 24(8). 470–477. 4 indexed citations
20.
Phillips, Robert A., et al.. (1993). Anticardiolipin antibodies in ischaemic heart disease: marker or myth?. Heart. 69(5). 391–394. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Usha Kim Breakdown of academic impact, for papers by J.J.N. Costa Breakdown of academic impact, for papers by Emma Jaeger Breakdown of academic impact, for papers by Kazuhide Okazawa Breakdown of academic impact, for papers by Ivana Majstorović Breakdown of academic impact, for papers by Ya‐Ping Ko Breakdown of academic impact, for papers by Monique G.C.T. van Oijen Breakdown of academic impact, for papers by Weimin Tsai Breakdown of academic impact, for papers by Caroline Lynas Breakdown of academic impact, for papers by Rkia Dardari
Rankless by CCL
2026